Bone Morphogenetic Proteins Market- Global Industry Forecast 2014 – 2022

Bone morphogenetic proteins (BMP) are naturally occurring proteins found in the human body. Identified in 1965 by Marshall Urist, bone morphogenetic proteins are among the most potent growth factors that induce mesenchymal stem cells to differentiate into osteoblast cells. Twenty different types of BMPs have been discovered to date; only BMP 2, 7 and 9 have osteoinductive property and have been proven to play a significant role in bone formation. However, of these, only BMP-2 and BMP-7 are commercially available. These proteins trigger intracellular signal pathways by binding to the receptor of the mesenchymal stem cells resulting in transformation of stem cells into tissue specific progenitor cells. These cells are involved in the synthesis of musculoskeletal tissue formation, extracellular growth and matrix.

Browse Full Bone Morphogenetic Proteins Market Report With Complete TOC @

http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

The bone morphogenetic proteins market report studies the current scenario as well as future market potential for bone morphogenetic proteins globally. The market overview section of the report comprises qualitative analysis of the overall bone morphogenetic proteins market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as event regulatory scenario and value chain analysis have also been provided. Value chain analysis includes the study of major steps involved in the recombinant bone morphogenetic proteins preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of recombinant bone morphogenetic proteins products.

The global bone morphogenetic proteins market has been segmented based on type, application and geography. Based on type, the global BMP market has been categorized into recombinant bone morphogenetic protein-2 (rhBMP-2) and recombinant bone morphogenetic protein-7 (rhBMP-7). Based on application, the bone morphogenetic proteins market has been classified into spinal fusion, trauma, reconstructive and oral maxillofacial surgery. The market for these types and applications has been extensively analyzed on the basis of factors such as product approval date, product demand, sales revenue, geographic presence and product features. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period from 2012 to 2022, considering 2013 and 2014 as the base years. The report also provides the compound annual growth rate (CAGR) for each segment for the forecast period from 2014 to 2022.

Browse Full Press Release Report:

http://www.transparencymarketresearch.com/pressrelease/bone-morphogenetic-protein-market.htm

Geographically, the BMP market has been classified into four major regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region have been provided for the period from 2012 to 2022, in terms of types and applications, along with the CAGR (%) for the forecast period from 2014 to 2022.

The bone morphogenetic proteins market report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global bone morphogenetic proteins market in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market shares. The report concludes with the profiles of major players in the global bone morphogenetic proteins market such as Medtronic plc, Stryker Corporation and Cellumed Co. Ltd. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

 

The global bone morphogenetic proteins market is segmented as follows:

Global Bone Morphogenetic Proteins Market Revenue, by Types

rhBMP-2

rhBMP-7

Global Bone Morphogenetic Proteins Market Revenue, by Application

Spinal Fusion

Trauma

Reconstructive Surgery

Oral-Maxillofacial

Global Bone Morphogenetic Proteins Market Revenue, by Geography

North America

Types

Applications

Europe

Types

Applications

Asia Pacific

Types

Applications

RoW

Types

Applications

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=2308

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Global Peptide Therapeutics Market to Value USD 25.4 Billion by 2018 - Transparency Market Research

Transparency Market Research has announced the addition of a new market intelligence report titled, “Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," to its offering. The report articulates that the global Peptide therapeutics market, which was worth approximately 14.1 billion in 2011, is estimated to grow at an average CAGR of 8.7% and reach an approximate value of USD 25.4 billion at the end of the forecast period that ranges from 2012 to 2018.

Browse Full Peptide Therapeutics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Peptides, the polymers that contain less than 50 amino acids and have molecular weights of less than 10 KDa, represent a group of substances with unique pharmacokinetic properties as compared to small molecule drugs and large proteins.

Peptides are known to play essential roles in modulating cellular functions and coordinating intercellular communications of our bodies. Scientists say that, as peptides are made from naturally occurring, metabolically tolerable amino acids, they are usually non toxic. So, the more one can utilize peptides in the making of a drug, the safer the drug shall be.

Peptide drugs also result in a much lesser risk of side-effects because of the close relationship between peptide drug molecules and the parent molecules that they are derived from. Side-effects, if any, when occur due to peptide drugs is most commonly a case of some local reaction or a dosage related issue.

The market for peptide drugs, which was not very developed and popular some decades back, is currently experiencing immense growth.

According to a recent report published by US market intelligence firm Transparency Market Research, the global market for Peptide Therapeutics, slated as

being worth 14.1 billion in the year 2011, is estimated to grow at an average CAGR of 8.7% and reach a value of USD 25.4 billion by the end of 2018.

The report adds that the market growth will be driven by factors such as a global rise in incidences of metabolic and cardiovascular diseases and huge technological developments in the field of peptide manufacturing. Especially, the market is estimated to achieve good growth as a result of enhancements in technology pertaining the introduction of niche methods such as solid phase peptide syntheses and introduction of many hybrid methods that are set to provide the best of both solid and liquid syntheses.

Application wise, this market is anticipated to experience a healthy growth in cancer peptide segment while the segment of neuropeptides is also estimated to grow at a vigorous rate of an average CAGR of 9.4% during the forecasted period. This market shall achieve this growth as a result of the rising cases of neurological disorders around the globe, the report added.

Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm

According to the report, the segment of hybrid technology of peptide synthesis is estimated to experience the highest growth of 12.1% during the forecasted period.

Though the current share of peptide drugs is only near to 1.55% of the overall medicine market, the numbers are dramatically increasing every passing year. The report estimates that currently over 120 new peptide drugs are in their clinical trial phase and some 500 to 600 are in their preclinical trial phases.

The new report on this market offered by Transparency Market Research offers a whole new outlook to the market activities, factors affecting its growth, factors restraining its growth, the various application fields of peptide drugs, the types of drugs currently available in the market, various routes of administration of drugs and the current technologies applied for manufacturing peptide drugs are discussed in detail.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=418

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Bioinformatics: A fusion of Computers and Biological Data:Transparency Market Research

Bioinformatics refers to an interdisciplinary approach to store, retrieve, organize and analyze biological and genetic data. A major part of this field comprises of the activity of developing software tools to generate and process useful biological data.

Browse Full Bioinformatics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/bioinformatics-market.html

Bioinformatics is not to be confused with biological computation. While bioinformatics simply makes use of computers for the better understanding of biology can its related concepts, biological computation refers to the subfield of computer engineering that seeks to build biological computers by using biology and bioengineering concepts.

Bioinformatics is, however, much similar to computational biology, only the scale of application and study differs - bioinformatics studies biological data on a molecular scale with keen attention to details while computational biology studies biological data by building large-scale theoretical models of biological systems and studying them with an abstract view to expand our knowledge about them.

Bioinformatics makes use of various laws of computer science, engineering, applied math and statistics to conceptualize biology in terms of bio-molecules (RNAs, DNAs) and process the resulting data in various ways in attempt to decode the code of life.

The use of computers has made the process of reading complex biological data much faster and efficient than before. Huge databases and information systems are used to store and retrieve data; analytical algorithms in soft computing, artificial intelligence, data mining, image processing, etc. are used to analyze data; algorithms in turn depend on theoretical principles of statistics, applied and discrete mathematics, system theory and control theory. As such, bioinformatics uses a good mix of many fundamental principles as well as many applied theories and sciences to manage biological data.

Browse Full Press Release Report:http://www.transparencymarketresearch.com/pressrelease/global-bioinformatics-market.htm

Aims of bioinformatics

Bioinformatics has threefold aims. Firstly, it manages data in such a manner that it becomes quite easy for researchers to access existing data and submit new data as they are produced. While data storage is an essential task for data management, any kind of data is practically useless unless it is analyzed. Thus, the purpose of bioinformatics is extended further because of data analysis.

The second aim of bioinformatics is to develop systems and tools to analyze data properly. For instance, after having a particular protein sequenced, it is necessary to compare it with a previously sequenced sample. To do this, a program a lot more advanced than a simple text-based comparator is required to understand the biological significance between the differences as well as the similarities in the two sequences studied. Bioinformatics aims at development of such complex tools by using expertise in computational theory and biological understanding.

The third aim of bioinformatics is to analyze the biological data through the use of complex mechanisms and convert the data in such a form that is biologically meaningful. In traditional biological studies, examining individual systems and comparison with only a few related fields was possible. But Bioinformatics has allowed the global analysis and comparison of data available from a variety of fields. Clearly, developing methods to assess the differences between different varieties of biomolecules and identifying similarities over a wide range of dissimilar sources is an essential aspect of managing the huge volumes of data and thus of bioinformatics.

Conclusion:

This field, which was originally developed for the analysis of biological sequences, has now grown to encompass a wide range of areas such as genomics, gene expression, structural biology, etc.

Almost all studies in bioinformatics underpin to two basic approaches. First is that of comparing and grouping biological data according to biological similarities and the second that of analyzing one type of data and using the information thus obtained to infer the observations from some other type of data.

These two approaches in bioinformatics are reflected in the main aims of the field that are storing, organizing and analyzing biological data with keen attention to details on a molecular scale. This has allowed bioinformatics in providing not only greater depth but also adding the dimension of breadth to biological investigations.

This has essentially provided us the opportunity to study individual systems in details with the ones that are related to reveal the similar traits between some systems and underline some unusual features, if any, which are unique

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=656

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.



Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Global Array Instruments Industry: North America to Continue to Be Market Leader

Array instruments are devices that assist microarrays in measuring the gene expression levels concurrently in a single reaction and also in genotyping various regions of genome. A microarray is a cluster of microscopic spots of RNA, DNA, oligo-nucleotides, peptides, proteins, tissues, cells, and other compounds that are attached to a solid substrate. The concept and methodology of microarray was originally introduced in the year 1983 by Tse Wen Chang in a scientific journal. This traditional biotechnological instrument is gaining acceptance as a rapidly evolving technology.

Browse Full Global Array Instruments Market Report With Complete TOC @ http://www.transparencymarketresearch.com/global-array-market.html

The global array market keeps on shifting focus from research and development devices towards various applications in diverse areas such as clinical diagnostics, drug discovery, and sequencing. This technology is majorly applied in cancer detection and treatment, gene expression, SNP genotyping, agricultural biotechnology, genomics, proteomics, and drug discovery. The development in microarray technology assisting in disease detection and drug response are likely to stimulate the growth of the array instruments market. The microarray technology has also been successfully employed in environmental sciences, toxicogneomics, bio-defense, veterinary, agriculture research, and forensics.

The increasing applications of microarrays in life sciences and drug discovery are triggering the demand for microarrays, resulting in the growth of the global market for array instruments. The demand for microarray technology to detect cancer as well as in routine usage is expected to be propelled by the increased rate of production and growth in labeling and diagnosis in near future. Robotics is also playing a key role in laboratory automation to fuel the global array instruments industry.

On the other hand, low acceptance and penetration rate in developing economies owing to the high cost of microarray technology is negatively affecting its usage. Similarly, the introduction of newer technologies is increasing the competition for microarray technology, which is affecting the development of the industry. Also, the lack of effective data analysis tools is likely to restrict the market growth in the near future.

Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/array-instruments-market.htm

The global array instruments industry reached US$0.87 billion in 2014. It is likely to rise at a CAGR of 4.3% from 2014 and 2020, to reach an expected value of US$1.12 billion by the end of the forecast period.

DNA microarray is the largest market segment according to the technologies employed in the global array instruments industry. The DNA microarray technology held almost 50% of the overall array instruments industry. It is anticipated that the global industry for DNA microarray will expand at a CAGR of 3.9% during the forecast period. In terms of end users, the research and development segment is likely to dominate the global array instruments market during the forecast period.

North America is the leading regional market for array instruments with 50% share of the overall market. The array instruments market in Europe hold the second position occupying almost 30% of the total share. The array instruments market in North America reached a value of US$417.4 million in 2014. It is expected that it will worth US$526.4 million in 2020. The emerging economies in Asia Pacific, Middle East, and Latin America are likely to experience rapid development till 2020. The enhancement in medical and healthcare infrastructure and rising preference for easier and safer targeted therapies are the main factors fueling the growth in these regional markets.

The global array instruments industry is highly fragmented in nature having a number of major and minor players participating in the market. ArrayIt Corporation, Thermo Fisher Scientific, Affymetrix, Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., and Illumina, Inc., Molecular Devices, LLC, and Agilent Technologies, Inc. are the prominent players occupying around 80% share of the overall array instruments market. Leading companies are investing heavily in automation of systems that are expected to reap great returns for them in the near future.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=495

About Us
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Regenerative Medicine Industry in Asia Pacific to Show Highest Growth Rate between 2013 and 2019

Regenerative medicines possess the distinctive capability to repair, reinstate, and regenerate tissues and organs damaged owing to injuries, diseases, or because of natural progression of age. These regenerative medicines are capable of re-establishing the functionality of tissues and organs. These medicines are applicable in a broad range of degenerative disorders such as dermatology, cardiovascular and neurodegenerative diseases, and orthopedic applications. Medical professionals and scientists are researching to develop technologies based on genes, biologics, somatic and stem cells.

Browse Full Global Regenerative Medicine Market Report With Complete TOC @ http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Technological Development to Drive Global Regenerative Medicine Industry

The technological development in tissue engineering and stem cell therapy is likely to augment the growth in the global regenerative medicine market particularly the bone and joint segment. In addition to this, the rising prevalence of bone and joint disorders has also caused the regenerative medicine market to grow at a healthy pace. However, some factors such as strict regulatory measures, ethical issues related to stem cell therapy, and infections occurring post implant are likely to hamper the development in the global market for regenerative medicine during the period of 2013 to 2019.

Biomaterial, stem cell therapy, and tissue engineering are the three segments of the global regenerative medicine industry according to the technologies employed in this market. In 2012, the biomaterials segment occupied the biggest share in the global regenerative medicine industry pertaining to bone and joint because of the strong demand for biomaterials and favorable reimbursement policies in the global regenerative medicine market. On the other hand, the high cost of biomaterials would prove to be a restricting factor to the growth of the global market to a large extent in the coming years.

Post Implantation Infection to Hamper Growing Regenerative Medicine Industry

Osteoarticular diseases, bone graft substitute, autogenic bones, allogeneic bones, and others are the categories of the global market for regenerative medicines based on various applications of these medicines. The bone graft substitute segment held the biggest share in the overall regenerative medicine application market in 2012, due to the growth in the demand for bone graft substitute in orthopedic surgeries. But, post implantation infection linked with bone graft substitute is considered as a critical factor that can limit the global demand for bone graft substitutes.

The regenerative medicine market concerning bone and joint is regionally distributed into regions such as North America, Europe, Asia Pacific, and Rest of the World. The market in North America held the biggest market share for regenerative medicine across the globe in 2012 owing to the rise in orthopedic reconstructive surgeries and introduction of technically advanced medical products and devices.

Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

Europe qualified for the second largest position in the global regenerative medicine industry based on bone and joint in 2012. A huge base of geriatric population is the most important factor that drives the growth of regenerative medicine industry in this region. Asia Pacific is likely to exhibit exceptional growth with the highest growth between 2013 and 2019 owing to the large base of prospective reconstructive surgery patients and support from federal government.

Global Regenerative Medicine Industry to reach US$6,473 million by 2019

In 2012, the global regenerative medicine industry with reference to bone and joint had reached a value of US$2,589.5 million. It is estimated that this industry will expand at a CAGR of 12.8% between 2013 and 2019 and will attain an expected value of US$6,473.4 million by the end of the forecast period.

The global market for regenerative medicine is highly fragmented. The key players of this industry are Stryker Corporation, Zimmer Holdings, Inc., CONMED Corporation, Baxter International, Inc., Anika Therapeutics, Inc., Medtronic, Inc., Smith & Nephew plc, DePuy Synthes, Inc., and Arthrex, Inc.

In May 2013, Smith & Nephew procured an Indian medical technology firm named Sushrut Surgical Pvt. Ltd., whose product portfolio consists of spine salvage products, limb salvage products, and trauma implants and instruments. This procurement would expand the business and improve the product portfolio of Smith & Nephew. It would also help the firm in seizing a lucrative share in the Asia Pacific market for regenerative medicine.

Request a Brochure of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=419

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Global Aptamers Industry: Asia Pacific to Become Fastest Developing Region

Aptamers are single-stranded RNA or DNA molecules that can bind to pre-selected target molecules such as peptides and proteins with high specificity and resemblance. These molecules can take various shapes owing to their propensity to create helices and single-stranded loops, which explains their versatility in binding these diverse targets. These aptamers are utilized as sensors and therapeutic devices. They are also used to control the cellular procedures as well as guide drugs to their specified cellular targets. Differing to the original genetic material, their specifications and characteristics are not directly identified by their main sequences, but by their triennial structure.

Browse Full Global Aptamers Market Report With Complete TOC @ http://www.transparencymarketresearch.com/aptamers-market.html

The global industry for aptamers is an emerging market, largely considered as a replacement to antibodies in the medical as well as the healthcare industry. It is likely to expand rapidly in varied application areas such as diagnostics and therapeutics. The aptamer technology is broadly applied in laboratory diagnosis, disease treatment, pharmaceutical studies, molecular recognition, and drug discovery. Additionally, these aptamers play a significant role in the production of better and cost-efficient medicines.

The global aptamers market is experiencing a rapid growth owing to the continuous efforts by major participants to develop new and innovative applications in the areas of therapeutics, diagnostics, and research using aptamer technology. In addition to this, the special features of aptamers such as high specificity, cost-effective production, and low immunogenic properties are expected to attract researchers to raise investments in the global aptamers market, thereby propelling the market growth. However, ethical issues and strict regulations associated with aptamers will restrict the growth of this market in future.

In 2012, the global aptamers industry had reached US$93.0 million. It is estimated that this market will be expanding at an impressive CAGR of 73.1% during the period of 2013 to 2019 and will reach US$4,333.0 million by the end of the forecast period.

Global Aptamers Industry: Asia Pacific to Become Fastest Developing Region

The aptamers market in North America held for the largest market share, which was more than 45% of the global aptamers industry in 2012. Europe held the second largest share of the overall market. Asia Pacific is likely to become the fastest developing region owing to the increasing initiatives started by the governments for the advancement of the aptamer technology loaded with enormous growth opportunities.

Based on types of aptamers, nucleic acid aptamers market was considered as the biggest market segment in 2012. This trend is expected to continue as this segment will retain its dominance, exhibiting the highest growth rate during the forecast period. The development in this segment is credited to increase in the usage of nucleic acid aptamers in diagnostic applications added with rise in the research and development activities.

On the basis of the application, the diagnostics market held the biggest market share in the global aptamers industry in 2012. The availability of several diagnostic kits produced by major players for in vitro diagnosis was the key driver for this market. However, the therapeutics market is likely to expand at the highest growth rate owing to the increase in the research and development activities to develop innovative therapeutic agents.

Browse Full Press Release Report :

http://www.transparencymarketresearch.com/pressrelease/aptamers-market.htm

Global Aptamers Industry: Rise in Scientific Research Activities to Boost Market Growth

CD Genomics, Ophthotech Corporation, NOXXON Pharma AG, Aptamer Sciences, Inc., Aptagen, LLC, Neo Ventures Biotechnology, Inc., TriLink Biotechnologies, Inc., Bioapter S.L., Base Pair Biotechnologies, Inc., Vivonics, Inc., Aptamer group, Regado Biosciences, Inc., Optech Biotech, AM Biotechnologies, LLC, and Somalogic, Inc. are the major players participating in the market for aptamers across the globe.

The rise in scientific research activities regarding aptamer technology and increase in the participation of private firms for the development of aptamers is likely to boost the growth of this market, worldwide. Apart from this, the joint efforts of the major players to develop inventive aptamer technologies is expected to act as the key driving force behind the growth of this market.

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1335

About us:

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

what are the major factors of Life Science Reagents Market

Consumption of life science reagents has been increasing due to rapidly developing technologies and increasing use of life science technologies. Life science reagents are commercially available in solid as well as in liquid forms. Life science reagents market report covers the market analysis for various reagents used in the biotechnology and life sciences. Continuous innovation in biotechnology is driving the life science reagents market towards remarkable growth. The stakeholders for life science reagents market study include manufacturers and providers of life science reagents.

Browse the full Life Science Reagents Market report at http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html

The global life science reagents market is categorized based on various products that are commercially available and end users of life science reagent products. The different product categories covered in the life science reagents market report include polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, flow cytometry reagents, chromatography reagents, in-vitro diagnostic (IVD) reagents and others (gene expression reagents, mass spectroscopy reagents and transfection reagents). The end users for the life science reagents market comprise commercial and contract manufacturers, research and academic institutes, hospital and clinical laboratories and forensic laboratories. A detailed market analysis and revenue forecast for above-mentioned segments has been provided in the life science reagents market study, in terms of USD million for the period 2011 to 2019. The life science reagents market report also provides the compounded annual growth rate (CAGR %) for each product type and end user segment for the forecast period 2013 to 2019, wherein the market size estimations have been made considering 2012 as the base year.

In terms of geographical distribution, the global life science reagents market has been classified into four geographical areas, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market size (in terms of USD million) of the above mentioned regional markets has been provided in the life science reagents market report for the period 2011 to 2019 along with their growth rate (CAGR %) for the period 2013 to 2019. The life science reagents market study further offers recommendations and highlights of the current industry trends of life science reagents, which would be useful for the established and emerging players who wish to, enter the market in the near future for strengthening and securing their position in the global life science reagents market.

Browse the full Press Release report : http://www.transparencymarketresearch.com/pressrelease/life-science-reagents-market.htm

The executive summary of the life science reagents market report includes market snapshot of the industry. In addition, comparative analysis of the global life science reagents market by geography in terms of value % for the years 2012 and 2019 is also included in the executive summary. The market overview section of the life science reagents market report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of life science reagents market. Impact factors such as market attractiveness analysis by geography in terms of value (%) for the year 2012 and Porter’s five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario of the global life science reagents market.

The life science reagents market study concludes with company profiles section which includes key information such as company overview, financial information, business strategies, product portfolio, and recent developments about the major players in this market. Some of the key players profiled in the life science reagents market report include Abbott Laboratories, Agilent Technologies, Lonza Group Ltd., Promega Corporation, Sigma Aldrich Corporation, Merck Millipore, Siemens Healthcare and Bio-Rad Laboratories, Inc.

The global life science reagents market is segmented as follows:

Life Science Reagents Market, by Product Type

Polymerase chain reaction (PCR) reagent kits

Cell and tissue culture reagents

Flow cytometry reagents

Electrophoresis reagents

Chromatography reagents

In-vitro diagnostics (IVD) reagents

Others (gene expression reagents, mass spectroscopy reagents and transfection reagents)

Life Science Reagents Market, by End User

Commercial and contract manufacturers

Research and academic institutions

Clinical laboratories

Forensic laboratories

Life Science Reagents Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1162

About Us



Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.



TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Immunoprotein Diagnostic Testing Industry: Oncology Testing Market to reach US$4,943 million by 2019

The immunoprotein diagnostic testing is the procedure of diagnosing the concentration of immunoproteins in the body of a living organism. Immunoprotein is a protein, which has immunological abilities providing immunity against pathogenic substances or organisms. These proteins create the integrated body system of cells, tissues, organs, or cell products to neutralize antigens. These proteins also enable the detection of many diseases as they exhibit an abnormal rise in the blood concentration in the diseased state. When exposed to antigen, the levels of these proteins raise ten to hundred folds within one or two days. The application of these immunoproteins has changed their paradigm to rapid testing from microbial testing.

Browse the full Immunoprotein Diagnostic Testing Market Report at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

The rise in the need for quick and accurate detection of the diseases coupled with the increasing demand for precautionary healthcare in emerging economies is the major driving force behind the growth in the global immunoprotein diagnostic testing industry. The powerful global network of distributors is another factor fueling the developing market. Apart from this, the technical advancement and the commoditization of products are also expected to drive the market in the coming years.

In contrast to this, the high cost of diagnosis and the deployed base of conventional ELISA test are the main hindrances limiting the growth of the global immunoprotein diagnostic testing industry. However, immunochromatography, research and development, and expansion of the immunoprotein diagnostic testing industry in emerging economies will cater for huge opportunities for the increment in the global immunoprotein diagnostic testing market in near future.

Enzyme-based immunoassay, immunoturbidity assay, immunofluorescence assay, radioimmunoassay, chemiluminescence assay, and immunoprotein electrophoresis are segments of immunoprotein diagnostic testing industry based on the assay technology.

The chemiluminescence assay market is recognized as the fastest developing market segment of the immunoprotein diagnostic testing industry. The sensitivity, simplicity in utilization, and the broad array of application are the reasons behind this development. Contrarily, the radioimmunoassay market is likely to decline as it is being substituted by better and more secure technologies such as chemiluminescence assay, ELISA, immunofluorescence assay, and others.

The restrictions imposed by the governments on the utilization of radioactive substances have significantly affected the growth in the immunoprotein diagnostic testing market. The compliance with regulatory firms, high cost of assay devices and safety equipment have further hampered the growth of the radioimmunoassay market. The immunofluorescence assay and immunoturbidity assay industries will be developing at a moderate CAGR of around 5% during the period of 2013 to 2019.

Browse the full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/immunoprotein-diagnostic-testing.htm

Based on the type of immunoprotein tests, the global immunoprotein diagnostic testing market is classified into haptoglobin diagnostic tests, complement system protein diagnostic tests, free light chain diagnostic tests, C-reactive protein diagnostic tests, immunoglobulin diagnostic tests, and prealbumin diagnostic tests. Among these, the C-reactive protein or CRP diagnostic tests market has attracted significant focus in the past due to the efficacy of the test in diagnosing disorders related to inflammation accurately.

Infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing are the various market segments based on the application of immunoprotein diagnostic testing. The oncology testing market is likely to generate the biggest share in the overall revenue the global market for immunoprotein diagnostic testing industry is expected to generate during the period of 2013 to 2019. The market for oncology testing will develop at a CAGR of 6% during the period of the forecast, and reach a value of US$4,943.0 million by the end of the forecast period.

In 2012, the global industry for immunoprotein diagnostic testing was valued at US$11,019.7 million. It is expected the global immunoprotein diagnostic testing market will reach US$15,351.0 million in the end of the forecast period, reporting a CAGR of 5.7% during the period of the forecast.

Abcam PLC, Siemens AG, Enzo Life Sciences, Inc., Randox Laboratories Ltd., Thermo Fisher Scientific, Inc., DiaSorin SPA, Fujirebio Diagnostics, Inc., Roche Holding AG, Omega Diagnostics Group PLC, The Binding Site Group Ltd., and Abbott Laboratories, Inc. are the major players participating in the immunoprotein diagnostic testing market.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1253

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Polymerase Chain Reaction: Commercial Labs Provide Solution to Restricted Global Market

Kary Mullis in the 1980s developed a revolutionary technique that is now the basis of the global polymerase chain reaction (PCR) market. The basic concept of PCR is to use a DNA polymerase to synthesize completely new strands of DNA. These strands will be similar to the template DNA strand used. One of the core requirements in the process is the addition of a primer. This is required because a DNA polymerase can only add a nucleotide to a 3’-OH group that already exists. The primer helps the polymerase to add the first nucleotide. Using this method, a scientist can create billions of copies of any specific sequence he/she wants. The core components of PCR are therefore a DNA template, a DNA polymerase, and nucleotides.

Browse Full Global Polymerase Chain Reaction Market Report With Complete TOC @ http://www.transparencymarketresearch.com/pcr-technologies.html

The techniques used in the global PCR market have created a giant scope of innovation in the world of science in terms of DNA-based research molecular diagnostics. PCR allows for the absolute quantification of DNA and RNA, both of which are genetic materials.

Commercial Labs Boost the Global PCR Market

Till recent times, the global PCR market has found scope mostly in pharma and biotechnology industries apart from research institutions. The rise of commercial diagnostic laboratories is set to change this confined trend. A large number of labs, both private commercial and government, are beginning to prefer PCR for the accurate diagnosis of life-threatening diseases including cancer and Ebola. Large players in the diagnostics industry are now building standalone labs with minimal infrastructure to provide PCR.

Player Trends and Innovations that Drive the Global PCR Market

All the top companies that operate in the global PCR market are currently working on developments that enhance the functionalities in it. This includes creating a broader list of tests and a higher level of specificity and sensitivity. Some of the key innovations that have defined the global PCR market today are the significant reduction in turnaround time, the ability to create automated workflow, and higher productivity. All developments in the global PCR market focus on the fact that there needs to be an extremely high level of accuracy in the detection and amplification of genetic materials.

There is a major shift in technologies happening in the global PCR market. This involves the increasing preference of real time and/or digital PCR systems. The market’s innovations will create a stronger foundation for future activities. For example, the introduction of QX200 Droplet Digital PCR system by Bio-Rad offers a plethora of tests for molecular diagnostics. Their improved workflow will reduce overall costs in the global PCR market.

Browse Full Press Release report : http://www.transparencymarketresearch.com/pressrelease/pcr-technologies.htm

Reagents and Consumables Dominate the Global PCR Market

The largest products segment in the 2013 global PCR market was reagents and consumables, when it generated a total of US$4,072.2 million for multiple companies. As for the applications segment, more than 48% of the 2013 global PCR market was held by life sciences. Clinical diagnostics held more than 33% of the market share in the same category. Life sciences dominates this category due to a greater level of acceptance of PCR oriented methods in cancer research, which happens to be one of the oldest application segments in the global PCR market. Academics and research has remained the largest end user of the global PCR market for the longest time and continued its dominance till 2013.

The global polymerase chain reaction market had a past worth of US$6.1 billion at the end of 2013. Market analysts now say that this market is currently developing at a compound annual growth rate of 6.6% between 2014 and 2020. If this growth rate remains unchanged, the global polymerase chain reaction market could potentially be worth US$9.6 billion by 2020. With its wide application base and growing number of commercial labs, the market is set to show a good deal of promise to all the players in it.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=830

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.